Sebivo prevents hepatitis B perinatal transmission

Published: 2011-02-08 06:58:00

Updated: 2011-02-08 06:58:00

Limited use of Sebivo (telbivudine) in highly viremic pregnant women can reduce perinatal hepatitis B virus (HBV) transmission to infants, according to the results of a study presented at The Liver Meeting 2010: American Association for the Study of Liver Diseases 61st Annual Meeting.

The stu...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK